Medication info

Riglen 5mg Tablet (Linagliptin)

Prescription medicationTabletExpired
Ingredient · strength
Linagliptin›5mg / 1 tablet
Manufacturer / importer
N BK Pharmaceutical Co., Ltd.
Appearance
Bright red round film-coated tablet
Packaging
30 tablets - 30 tablets/bottle, 30 tablets - 10 tablets/Alu-Alu [×3]
Approval status
Expired

MFDS item code 202004123 · Approved 2020.05.29

This product's status changed to Expired on 2025.05.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
The recommended dose of this medicine is 5mg once daily. It may be taken with or without food. When coadministered with insulin or an insulin secretagogue (e.g., sulfonylureas), a lower dose of insulin and insulin secretagogues may be required to minimize the risk of hypoglycemia.

Ingredients

Manufacturer
N BK Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

  • Difficulty in blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used in conjunction with diet and exercise to improve blood sugar control in patients with type 2 diabetes. It can be administered as a monotherapy, and if blood sugar control is insufficient with monotherapy, it can be used in combination with metformin, sulfonylureas, insulin, or these medications. Additionally, this medication can be added to enhance the effect in patients who have difficulty controlling blood sugar with existing therapies. This medication is effective in supporting blood sugar control in various combination therapy situations; thus, it is very useful in the treatment of type 2 diabetes.

Dosage and Administration

Adult dosage

The recommended dose of this medicine is 5mg once daily. It may be taken with or without food. When coadministered with insulin or an insulin secretagogue (e.g., sulfonylureas), a lower dose of insulin and insulin secretagogues may be required to minimize the risk of hypoglycemia.

Precautions

This medicine should not be used in individuals who have allergic reactions to its active ingredient or other components. This medication should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. When used with other drugs that can cause hypoglycemia, the risk of hypoglycemia may increase, so caution is warranted. In particular, when used in combination with insulin or sulfonylureas, the possibility of hypoglycemia may increase, and dose adjustments may be necessary. Experience with this medication in patients with heart failure is limited, so it should be used cautiously. There is a possibility of acute pancreatitis occurring during the administration of this medication; therefore, if symptoms of pancreatitis such as severe abdominal pain appear, the medication should be stopped immediately, and a doctor should be consulted. A skin condition known as bullous pemphigoid may occur; if blisters or sores appear on the skin, the doctor should be informed immediately, and this medication should be discontinued. Symptoms of hypoglycemia may frequently occur during the use of this medication, hence symptoms should be closely monitored, and appropriate actions should be taken if needed. Clinical trial results indicate that this medication has been safely used in most patients, although rare adverse reactions such as skin rashes, gastrointestinal disturbances, and arthralgia have been reported. This medication is not recommended for use in pregnant women, and caution is advised for nursing women. Safety and efficacy in children under 10 years have not been established, so it is advisable not to use it in this age group. It can be used in the elderly without special dose adjustments, and patients with decreased kidney or liver function can also be administered without dose adjustments. In case of overdose, as there are no specific antidotes, general supportive treatment such as removing remaining medication from the gastrointestinal tract and observing symptoms should be carried out. This medication should be stored out of reach of children, and it is advisable not to transfer it to another container.

Side effects

Hypoglycemia, nasopharyngitis, hypersensitivity, angioedema, urticaria, hypertriglyceridemia, hyperlipidemia, cough, pancreatitis, constipation, oral ulcer formation, rash, vesicular pemphigus, severe and disabling arthralgia, rhabdomyolysis, weight gain, increased lipase, increased amylase, dyspepsia, edema, facial edema, peripheral edema, weight loss, increased appetite, constipation, abdominal pain, enterocolitis, intestinal obstruction, gastroenteritis, shingles, cystitis, acute pyelonephritis, bronchitis, vestibular neuronitis, sepsis, pneumonia, decreased appetite, dehydration, hyperglycemia, cerebral infarction, speech disorder, Alzheimer's dementia, chest pain, fever, facial swelling, fatigue, death, chronic obstructive pulmonary disease, asthma, diabetic foot, skin lesions, liver metastasis, acute leukemia, basal cell carcinoma, non-small cell lung cancer, malignant pericardial effusion, gastric cancer, rectal cancer, pancreatic cancer, meniscus injury, pneumoconiosis, congestive heart failure, angina pectoris, acute myocardial infarction, unstable angina, cardiac arrest, diabetic retinopathy, acute kidney injury, end-stage renal disease, acute cholangitis, acute cholecystitis, cholangitis, dizziness, kidney transplant failure, anemia, nausea, diarrhea, gastroesophageal reflux disease, gastritis, headache, paresthesia, postherpetic neuralgia, hemiparesis, syncope, drowsiness, chest discomfort, asthenia, pain, epistaxis, oropharyngeal pain, voice disorder, allergic rhinitis, exertional dyspnea, wet cough, rhinorrhea, lung mass, arthralgia, osteoporosis, arthropathy, musculoskeletal discomfort, myositis, myalgia, soft tissue mass, postmenopausal osteoporosis, rotator cuff syndrome, increased triglycerides in blood, urine albumin/creatinine ratio increased, positive urine leukocytes, decreased hemoglobin, increased potassium in blood, increased creatinine in blood, increased creatine phosphokinase in blood, increased ALT, increased AST, androgenetic alopecia, hyperhidrosis, dermatitis, anxiety, mood disorder, insomnia, depression, contusion, bone contusion, concussion, bone fracture, hand fracture, laceration, palpitations, dry eye, glaucoma, cataract, ocular discomfort, allergic conjunctivitis, polyuria, proteinuria, stress urinary incontinence, hematuria, hypotension, flushing, hepatic steatosis, cholelithiasis, hearing loss, erectile dysfunction, goiter, pruritus, hypertension, benign prostatic hyperplasia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. The storage temperature should be maintained at room temperature between 1 degree and 30 degrees Celsius. This helps in preserving the effectiveness and safety of the medication for a longer time.

Appearance and packaging

Appearance

Bright red round film-coated tablet

Package unit

30 tablets - 30 tablets/bottle, 30 tablets - 10 tablets/Alu-Alu [×3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.